Watch Now: mAbs and ADCs On Demand Event

by Jessica Hogan | April 5, 2023

mAbs Banner

Click HERE to watch the On Demand Event.


Building a Successful mAb Platform using the CHOZN® Cell Lines and UCOE® Technology
Steven Richardson, Technology Consultant, Upstream Bioprocessing

Developing a mAb expression platform is a critical and time-consuming task. The CHOZN® Expression Platform includes a ready-to-use, industry-leading CHO cell line that creates high-producing clones without needing process optimization.

Join us for an introduction to the CHOZN® cell line and how to bring your project from DNA to GMP production. We will also share information on our UCOE® technology, which improves plasmid integration and mAb expression levels to drive higher titers.

ADCs and the Growing Atlas of Bioconjugates
Kaelyn Wilke, Associate Director, ADC & Bioconjugation Services

Deemed “magic bullets” by some in the biotherapeutics community, antibody-drug conjugates (ADCs) chemically link the potency of small-molecule chemotherapies with the selective targeting of monoclonal antibodies (mAbs). Recently, non-traditional ADC components across the small-to-large modality space are used to form novel conjugates and reach new and diverse indications.

In this presentation, we will explore this growing atlas of bioconjugates.

From Discovery to Market Readiness, a CTDMO as an Enabler
Jean François Michel, Head of Commercial Manufacturing, Life Science Services
Jean-Baptiste Noirot-Cosson, Head of Manufacturing Science and Technology, Life Science Services
In early development, biotechs are challenged to move fast while generating data on their lead molecule and its manufacturability. How do you make sure that process data isn’t lost in translation between clinical and commercial manufacturing?
Here we present how biologics contract testing development and manufacturing (CTDMO) can be an enabler for innovators to bring their molecule to market. We’ll discuss the importance of tech transfer for market readiness, the impact of harmonized single-use equipment on faster validation, and our commercial production facility’s capacity and capabilities.

Click HERE to watch the On Demand Event.

Related Posts

Hiring Challenges in Bioprocessing for Start-ups

Creating Bottlenecks in Europe; Opportunities for Production Staff BioPlan Associates, Inc. Hiring of bioprocessing professionals has remained a…

When to sprint and when to breathe in the race from lab to clinic – 5 critical steps to success

As an early-stage or small-sized biotech company, you need to move fast and be nimble.  Success is measured…

Starting your journey into manufacturing – choosing a cell line development provider

One of the biggest decisions which any company developing biological medicines makes is to move forward to the manufacture of their product. …

A Streamlined Approach to Analytical Method Development and Implementation

The development and implementation of analytical methods are essential for success at all phases of a molecule’s journey,…

Scroll to Top